NASDAQ · Drug Manufacturers - General

Gilead Sciences Inc (GILD)

$146.12 +1.87%
Add alert
67 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$132.12+10.60%

Company profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$164.99B
P/E ratioNone
EPS$-2.65
Beta0.336
Dividend yield2.42%
52-week high$155.38
52-week low$106.44

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 72 LLY Lilly(Eli) & Company RSI 60 JNJ Johnson & Johnson RSI 62 BMY Bristol-Myers Squibb Company RSI 63 MRK Merck & Co Inc RSI 78 NVO Novo Nordisk RSI 50 ABBV Abbvie Inc RSI 64 AMGN AMGEN Inc RSI 74 GSK GSK Plc RSI 56 OGN Organon & Company RSI 75
Free forever

RSI alerts for GILD

Get an email the moment Gilead Sciences Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 4:18 AM EDT